Contractors open shop; India checks its exporters;

> NextPharma's Sterile Product Development Center outside of Brussels is now in business, having shipped its first formulated, manufactured and labeled GMP drug candidate for the trial of a controlled-release, anhydrous and lipid based formulation. Release

> Waymade Healthcare has cut the ribbon on a specialty-medication manufacturing facility, targeting drugs made for patients with such special needs as allergies to common pharma ingredients. Article

> Regulators in India are clamping down on drug exporters. Blog

> Berlin-based process-management solutions provider Pumacy Technologies has developed the KMmaster Life Science Edition as part of the EU's BIOsecure project for quality assurance. Release

> MWB Consulting, which advises international clients on development and postmarketing support of pharmaceuticals and medical devices, has joined SAFE-BioPharma Association. Announcement

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.